Until about 20 years ago, people in the advanced stages of age-related macular degeneration (AMD) were almost certain to lose their central vision. Without the ability to see faces, read or drive ...

AMD's performance on the stock market has been mixed throughout the past five years. However, all of AMD's key businesses seem set for healthy growth over the next five years, indicating that it ...